Correlation Between Exagen and Sera Prognostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Exagen and Sera Prognostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exagen and Sera Prognostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exagen Inc and Sera Prognostics, you can compare the effects of market volatilities on Exagen and Sera Prognostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exagen with a short position of Sera Prognostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exagen and Sera Prognostics.

Diversification Opportunities for Exagen and Sera Prognostics

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Exagen and Sera is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Exagen Inc and Sera Prognostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sera Prognostics and Exagen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exagen Inc are associated (or correlated) with Sera Prognostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sera Prognostics has no effect on the direction of Exagen i.e., Exagen and Sera Prognostics go up and down completely randomly.

Pair Corralation between Exagen and Sera Prognostics

Considering the 90-day investment horizon Exagen is expected to generate 3.1 times less return on investment than Sera Prognostics. But when comparing it to its historical volatility, Exagen Inc is 2.1 times less risky than Sera Prognostics. It trades about 0.05 of its potential returns per unit of risk. Sera Prognostics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  123.00  in Sera Prognostics on August 27, 2024 and sell it today you would earn a total of  531.00  from holding Sera Prognostics or generate 431.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Exagen Inc  vs.  Sera Prognostics

 Performance 
       Timeline  
Exagen Inc 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Exagen Inc are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Exagen displayed solid returns over the last few months and may actually be approaching a breakup point.
Sera Prognostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sera Prognostics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Sera Prognostics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Exagen and Sera Prognostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Exagen and Sera Prognostics

The main advantage of trading using opposite Exagen and Sera Prognostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exagen position performs unexpectedly, Sera Prognostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sera Prognostics will offset losses from the drop in Sera Prognostics' long position.
The idea behind Exagen Inc and Sera Prognostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios